Publication Opportunities for ACCORD 2026 Participants
All participants of the ACCORD 2026 Conference are invited to submit their conference papers to the IJMS Special Issue “Novel Strategies in the Development of New Therapies, Drug Substances and Drug Carriers, 4th Edition”.
Guest Editors:
• Prof. Dr. Andrzej Kutner, Medical University of Warsaw
• Prof. Dr. Geoffrey Brown, University of Birmingham
• Dr. Enikö Kallay, Medical University of Vienna
Special Issue link: https://www.mdpi.com/journal/ijms/special_issues/5O179HF78Z
IJMS is an international peer-reviewed open-access journal covering biochemistry, molecular and cell biology, molecular biophysics, molecular medicine, and all areas of molecular research. It is published semi-monthly by MDPI.
Conference papers may present research delivered as an invited lecture, short oral presentation, or poster (printed or spotlight). IJMS holds a JCR Q1 ranking in Biochemistry & Molecular Biology and is valued at 140 points by the Polish Ministry of Education and Science, with an impact factor of 4.9.
Deadline for manuscript submission: 30 June 2026.
Submissions are welcome from all fields of drug sciences, including (but not limited to):
• drug design and molecular modeling
• target identification
• lead generation and optimization
• medicinal and pharmaceutical chemistry
• drug carriers and dosage forms
• in silico, in vitro, ex vivo, and in vivo studies
• preclinical evaluation
Manuscripts from related disciplines contributing to the drug development process are also encouraged. All submissions will undergo standard peer review. Author guidelines and resources are available at: https://www.mdpi.com/authors.
ACCORD 2026 invited speakers receive a 20% discount on the Article Processing Charge.
Previous ACCORD Special Issues (2022 and 2024) have also been published as books:
• https://www.mdpi.com/books/book/7854-novel-strategies-in-the-development-of-new-therapies-drug-substances-and-drug-carriers-2-0
• https://www.mdpi.com/books/reprint/11768-novel-strategies-in-the-development-of-new-therapies-drug-substances-and-drug-carriers-3rd-edition
The forthcoming Special Issue (4.0), based on contributions from ACCORD 2022 and ACCORD 2024, will be published in the same format. Authors are encouraged to include the following footnote on the manuscript’s first page:
“Presented in part at the ACCORD 2026 Conference, Warsaw, Poland, May 27–29, 2026.”
Prospects in Pharmaceutical Sciences
Participants may also submit manuscripts to a regular or special issue of Prospects in Pharmaceutical Sciences, published by the Medical University of Warsaw, Pharmacy Department:
https://prospects.wum.edu.pl/index.php/pps/about.
The journal holds 20 points from the Polish Ministry of Education and Science and offers open-access publication of original articles and reviews in Polish (with an English abstract) or in English. Areas of interest include:
• pharmaceutical analysis
• biochemistry and biopharmacy
• biotechnology
• clinical pharmacy
• phytochemistry and herbal medicine
• pharmaceutical care
• drug synthesis and pharmaceutical technology
• food and nutrition sciences
• pharmacoeconomics, history of pharmacy, and didactics in medical professions
The journal provides immediate open access to all articles and charges no Article Processing Fees. Full-text content is available in the “Archives” section of the journal website. The publication is supported institutionally and organizationally by the Medical University of Warsaw.